Nitrosamine Testing

Nitrosamine Testing

Product

Information

Ensuring Pharmaceutical Safety and Compliance Nitrosamines can form during the manufacturing process of active pharmaceutical ingredients (APIs) and drug products. Because of their potential carcinogenic properties, nitrosamine impurities pose significant health risks to patients. Regulatory bodies like the FDA and EMA have set strict rules to manage these impurities. This makes nitrosamine risk assessments and testing vital for compliance and patient safety. Learn more here: https://www.cambrex.com/analytical-services/analytical-testing/nitrosamine-testing/
Supplied From
United States
Main Categories
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)Laboratory and Analytical Services
Cambrex1021Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical services. With over 45 years of experience and a team of 2,000 experts servicing global clients from North America and Europe, Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, solid-state science, material characterization, and highly potent APIs.

Log in

See all the content and easy-to-use features by logging in or registering!